Position in ANIX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,509,961
+$118,640 QoQ
Shares Held
539,272
0.0% QoQ
Ownership
1.59%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 61 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D.A. DAVIDSON & CO. holds $28,520,434 across 19 Biotechnology names. ANIX ranks #8 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
538,924 | $4,718,279 | |
| 2 | MRNA |
Moderna, Inc.
|
54,290 | $3,801,928 | |
| 3 | BEAM |
Beam Therapeutics Inc.
|
100,628 | $3,453,552 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
43,601 | $2,494,849 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,547 | $2,258,631 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
87,741 | $2,256,698 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
|
95,540 | $1,616,536 | |
| 8 | ANIX |
Anixa Biosciences Inc
This page
|
539,272 | $1,509,961 |
All Filings in ANIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,509,961 | 539,272 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,391,321 | 539,272 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,682,528 | 539,272 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,027,097 | 614,272 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,027,097 | 614,272 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,756,817 | 614,272 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $1,556,887 | 671,072 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,113,876 | 671,072 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,627,477 | 736,415 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||